Lunai Bioworks
LNAI
49 hedge funds and large institutions have $7.13M invested in Lunai Bioworks in 2024 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 5 closing their positions.
200% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 5
75% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 8
33% more call options, than puts
Call options by funds: $12K | Put options by funds: $9K
26% more funds holding
Funds holding: 39 → 49 (+10)
0.01% more ownership
Funds ownership: 0.12% → 0.13% (+0.01%)
71% less capital invested
Capital invested by funds: $24.8M → $7.13M (-$17.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$253K |
| 2 |
CF
Cantor Fitzgerald
New York
|
+$86.7K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$65.5K |
| 4 |
JP Morgan Chase
New York
|
+$62.6K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$53.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$135K |
| 2 |
Morgan Stanley
New York
|
-$84.7K |
| 3 |
AGM
Alpine Global Management
New York
|
-$81.9K |
| 4 |
TI
Tidal Investments
Milwaukee,
Wisconsin
|
-$57.2K |
| 5 |
BlackRock
New York
|
-$37.5K |
LNAI Hedge Fund Activity: Q3 2024 in Review
49 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q3 2024, worth a combined $7.13M — down 71% from $24.8M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new LNAI positions and 5 closed out — a net gain of 10 holders — while 14 added to existing stakes and 8 trimmed.
The largest buyer was Northern Trust, adding an estimated $253K. The largest seller was Geode Capital Management, cutting an estimated $135K.
- 49 institutional investors held Lunai Bioworks (LNAI) as of Q3 2024, up from 39 in Q2 2024.
- Funds reported $7.13M of Lunai Bioworks stock for Q3 2024, down 71% quarter-over-quarter.
- 15 funds opened new Lunai Bioworks positions in Q3 2024 and 5 closed out, a net change of +10 holders.
- The largest Lunai Bioworks buyer in Q3 2024 was Northern Trust, an estimated $253K added.
- The largest Lunai Bioworks seller in Q3 2024 was Geode Capital Management, an estimated $135K sold.
Based on aggregated 13F filings for Q3 2024.